Global diagnostics company Veracyte is acquiring Israeli cancer care startup C2i Genomics for $70 – 95 million.
US company Delinea has acquired Israeli cybersecurity Authomize for “several tens of million dollars”
Global diagnostics company Veracyte is acquiring Israeli cancer care startup C2i Genomics for $70 – 95 million.
US company Delinea has acquired Israeli cybersecurity Authomize for “several tens of million dollars”